Date: Tuesday, June 4, 2019
Session Name: Poster Session D: Psychosocial and Treatment Adherence
Session Time: 6:00pm-7:00pm
Presentation Time: 6:00pm-7:00pm
Location: Hall C & D
- Development of a Classification of Immunosuppressant Medication Nonadherence Tool to Enable the Objective Measurement of Immunosuppressant Medication Nonadherence in Kidney Transplant Patients
- Psychosocial Factors Associated with Medication Adherence Based on Self Reports in Kidney Allograft Recipients: Baseline Findings from the PRIMA (ImPRoving Adherence to Immunosuppressive Therapy by Mobile Internet Application) Study.
*Purpose: Nonadherence to immunosuppressive therapy is a risk factor for poor clinical and economic outcomes after kidney transplantation (KT). Brazil, having the largest public and full coverage transplantation program in the world, is a unique opportunity to understanding the multilevel correlates of non-adherence (patient, health care provider, transplant center, and healthcare system levels) independent from patients’ financial burden, currently understudied in KT.
*Methods: Applying a multi-staged sampling approach, we included 1,105 patients from 20 KT centers. Nonadherence to immunosuppressives (implementation phase) was defined as any deviation in taking or timing adherence and/or dose reduction assessed by the BAASIS©. Based on Bronfenbrenner’s ecological model, we analyzed multilevel factors through sequential logistic regression analysis.
*Results: Prevalence of immunosuppressive nonadherence was 39.7%. Factors associated with nonadherence were: at patient level – stable partner (OR:0.73; CI:0.565-0.95), taking immunosuppressives once a day (OR:2.57; CI:1.23-5.37), nonadherence to appointment keeping (OR:3.05; IC:2.07-4.48), nonadherence to physical activity recommendations (OR:1.82; CI:1.37-2.43); at transplant center level: centers of more than 500 beds (OR:0.62; CI:0.50-0.77), dissatisfaction with waiting room structure (OR:1.80; CI:1.38-2.33), consultation longer 30 minutes (OR:1.60; CI:1.19-2.14), patients’ perceived adequacy of consultation´s frequency (OR:0.64; CI:0.44-0.92).
*Conclusions: This is the first multicenter study to show multilevel correlates of nonadherence in KT patients. Multilevel strategies to tackle nonadherence should also address the post-transplant care.
To cite this abstract in AMA style:Sanders-Pinheiro H, Colugnati FA, Denhaerynck K, Marsicano EO, Medina JO, Geest SDe. Multilevel Correlates of Immunosuppressive Nonadherence in Kidney Transplant Patients – The Multicenter ADHERE BRAZIL Study [abstract]. Am J Transplant. 2019; 19 (suppl 3). https://atcmeetingabstracts.com/abstract/multilevel-correlates-of-immunosuppressive-nonadherence-in-kidney-transplant-patients-the-multicenter-adhere-brazil-study/. Accessed June 4, 2020.
« Back to 2019 American Transplant Congress